Heranba Industries Limited strengthens its growth strategy with the launch of Fentaamine and MycoHil, aiming to scale global presence and tap into the fast-growing crop nutrition market

Heranba Industries Limited is accelerating its diversification strategy with a formal entry into the fast-growing crop nutrition segment, as it targets Rs 2,500 crore in revenue for the current fiscal year under its Vision 2026 roadmap.

The company unveiled two new products—Fentaamine, a bio-stimulant designed to enhance plant metabolism and stress tolerance, and MycoHil, a biofertilizer aimed at improving nutrient uptake and soil health—signaling a shift toward integrated crop solutions that combine protection and nutrition. The portfolio has been developed in collaboration with a US-based multinational partner, aligning global R&D capabilities with Heranba’s domestic manufacturing strengths.

This strategic move positions Heranba to tap into a crop nutrition market growing at over 15 per cent annually, both in India and globally, while expanding its role beyond traditional agrochemicals into sustainable and precision farming inputs. The company is also scaling its international footprint across more than 80 countries, with plans to establish a presence in Dubai to strengthen access to Middle East and African markets.

To support its growth ambitions, Heranba is investing in manufacturing scale-up across its seven facilities, expanding contract manufacturing operations, and strengthening distribution through enhanced sales infrastructure, channel partnerships, and last-mile farmer engagement.